Sulforaphane has opposing effects on TNF-alpha stimulated and unstimulated synoviocytes.
Sulforaphane has opposing effects on TNF-alpha stimulated and unstimulated synoviocytes.
复制标题
DOI:
10.1186/ar4059
复制
发表时间:
2012-10-27
影响因子:
4.9
通讯作者:
Wruck CJ
中科院分区:
文献类型:
--
作者:
Fragoulis A;Laufs J;Müller S;Soppa U;Siegl S;Reiss LK;Tohidnezhad M;Rosen C;Tenbrock K;Varoga D;Lippross S;Pufe T;Wruck CJ
Rheumatoid arthritis (RA) is characterized by progressive inflammation associated with rampantly proliferating synoviocytes and joint destruction due to oxidative stress. Recently, we described nuclear factor erythroid 2-related factor 2 (Nrf2) as a major requirement for limiting cartilage destruction. NF-κB and AP-1 are the main transcription factors triggering the inflammatory progression in RA. We used sulforaphane, an isothiocyanate, which is both an Nrf2 inducer and a NF-κB and AP-1 inhibitor. Cultured synoviocytes were stimulated with sulforaphane (SFN) with or without TNF-α pre-treatment. NF-κB, AP-1, and Nrf2 activation was investigated via dual luciferase reporter gene assays. Matrix metalloproteinases (MMPs) were measured via zymography and luminex technique. Cytokine levels were detected using ELISA. Cell viability, apoptosis and caspase activity were studied. Cell proliferation was analysed by real-time cell analysis. SFN treatment decreased inflammation and proliferation dose-dependently in TNF-α-stimulated synoviocytes. SFN did not reduce MMP-3 and MMP-9 activity or expression significantly. Interestingly, we demonstrated that SFN has opposing effects on naïve and TNF-α-stimulated synoviocytes. In naïve cells, SFN activated the cytoprotective transcription factor Nrf2. In marked contrast to this, SFN induced apoptosis in TNF-α-pre-stimulated synoviocytes. We were able to show that SFN treatment acts contrary on naïve and inflammatory synoviocytes. SFN induces the cytoprotective transcription factor Nrf2 in naïve synoviocytes, whereas it induces apoptosis in inflamed synoviocytes. These findings indicate that the use of sulforaphane might be considered as an adjunctive therapeutic strategy to combat inflammation, pannus formation, and cartilage destruction in RA.
登录
查看更多内容
影响因子:
6.7
作者:
Brandenburg, Lars-Ove;Kipp, Markus;Wruck, Christoph J.
通讯作者:
Wruck, Christoph J.
影响因子:
27.4
作者:
Wruck, Christoph Jan;Fragoulis, Athanassios;Pufe, Thomas
通讯作者:
Pufe, Thomas
DOI:
10.1073/pnas.172398899
发表时间:
2002-09-03
影响因子:
11.1
作者:
Dinkova-Kostova, AT;Holtzclaw, WD;Talalay, P
通讯作者:
Talalay, P
影响因子:
7.4
作者:
Kaspar, James W.;Niture, Suryakant K.;Jaiswal, Anil K.
通讯作者:
Jaiswal, Anil K.
影响因子:
--
作者:
Kong, Jin-Sun;Yoo, Seung-Ah;Kim, Wan-Uk
通讯作者:
Kim, Wan-Uk